SunRegen Healthcare AG is a biopharmaceutical company based in Basel Area. It is focusing on innovative treatments for patients with ophthalmic diseases. The first drug candidate is in development for neurodegenerative eye disease and in evaluation for other neurodegenerative diseases. SunRegen team is composed of passionate, innovative and persistent experts who have track records of drug development, clinical research, commercialization and managementexperiences in big pharma.